Triphala Ingredients & Drug Interactions
What is this page for?
First and foremost: checking Triphala against your medications. The heart of this page is the interaction checker and the full interaction report — how this product’s ingredients may interact with prescription and over-the-counter medicines you may be taking.
Around that, we add a pharmacist’s high-level view of the product as a whole — what’s inside, the evidence for its stated use, how transparent the label is, and what safety data exists — so you can see the full picture in one place. It’s educational information from our licensed clinical databases and the clinical staff at HelloPharmacist — not medical advice — and we don’t sell or endorse products. Our editorial policy
Triphala is a dietary supplement by Banyan Botanicals with 3 active ingredients. Its ingredients are commonly taken for digestive support and constipation, antioxidant support, oral and throat health.Based on those ingredients, 214 medications have a known interaction with it, the most serious rated moderate. The ingredients most likely to interact are Emblica officinalis, Terminalia chebula, Terminalia bellirica. Use the checker below to test your specific medication, or read the full HelloPharmacist Interaction Report.
Check Your Meds Against Triphala by Banyan Botanicals
Ask about any prescription or over-the-counter medication and we check it for interactions with Triphala by Banyan Botanicals — and tell you which ingredient is responsible.
AI summaries are generated from our interaction database for education only — always confirm with your pharmacist. How we use AI
Ask the Pharmacist
A licensed pharmacist will answer your question by email — free, usually within 24 hours.
Got it — thank you!
A licensed pharmacist will answer within 24 hours. Keep an eye on your email (worth checking spam, just in case).
HelloPharmacist Scorecard of Triphala by Banyan Botanicals
Our pharmacy team’s full take, with four database checks built into the cards below — a summary of what is known, not a grade of the product itself.
What’s inside
Full disclosure
Triphala contains three active botanical ingredients: Terminalia chebula, Indian gooseberry (Emblica officinalis), and Terminalia bellirica. This is a powder formulation with no other inactive ingredients listed.
The product is a traditional Ayurvedic blend designed to combine the properties of all three fruits.
Does it work?
Moderate evidence
The evidence for Triphala's effectiveness is limited. Terminalia chebula and Terminalia bellirica both have insufficient reliable evidence to rate for constipation, diarrhea, respiratory tract infections, and cough.
Indian gooseberry shows possibly effective evidence for gastroesophageal reflux disease (GERD) and possibly effective evidence for dyslipidemia (elevated blood lipids), but insufficient evidence for high cholesterol and hair loss. None of the three ingredients have established evidence for diabetes.
Overall, human research on Triphala itself is sparse, and we hold no effectiveness ratings specific to the combined product.
How safe is it?
Well-documented data
Triphala is generally used in traditional medicine, but human safety data are limited and product quality varies. In a small clinical study, two adults developed a hypersensitivity rash (one with facial swelling) minutes after taking Triphala with guggul extract, though it's unclear which ingredient triggered the reaction.
Indian gooseberry has been associated with epigastric discomfort or indigestion in up to four trial participants, and isolated reports of fatigue and musculoskeletal pain in single individuals. The safety data advises against use during pregnancy for all three ingredients due to insufficient information.
Breastfeeding safety is not established for any of them, so avoidance is recommended. There is not enough data to know if Triphala is safe while nursing—talk with your doctor or pharmacist for personalized guidance.
Meds to double-check
Moderate interaction found
Before taking Triphala, double-check if you're on diabetes medications (blood sugar control may be affected), anticoagulants or antiplatelet drugs like aspirin or clopidogrel (bleeding risk may increase), muscle relaxants like chlorzoxazone, or omeprazole for heartburn. These Moderate-severity interactions need a conversation with your doctor or pharmacist before you start.
The bottom line
Scorecard at a glanceFully disclosed formula with some supporting evidence behind its ingredients' uses. Moderate medication interactions have been identified, and safety information is well characterized.
Triphala is a traditional botanical blend with limited human safety and effectiveness data. If you take diabetes medications, blood thinners, aspirin, muscle relaxants, or heartburn medications, check with your doctor or pharmacist before starting this product—it may affect how those drugs work or raise your bleeding risk.
Pregnant women and those breastfeeding should avoid it. Use the interaction checker below to verify your specific medications.
Educational only — not medical advice; always confirm with your pharmacist. Our editorial policy · How we use AI
Assessment coverage: 3 of 3 active ingredients matched to our full ingredient reviews (monographs). Based on the product label dated Mar 22, 2024.
This Scorecard evaluates available label information, ingredient evidence, and known medication-safety considerations. It does not independently verify product identity, purity, potency, contamination, or manufacturing quality. How these ratings are computed
General information
Key facts about Triphala, straight from the product label.
| Brand | Banyan Botanicals |
|---|---|
| Barcode (UPC) | 618192075036 |
| Net contents | 3.19 Ounce(s); 90 Gram(s) |
| Market status | On market |
| Date entered into DSLD | Mar 22, 2024 |
| DSLD ID | 305741 |
| Product type | Botanical |
| Supplement form | Powder |
| Dietary claims / uses | All Other |
| Intended target group(s) | Adult (18 - 50 Years), Organic |
Everything in this section is reproduced from the manufacturer’s own product label — it’s the label speaking, not HelloPharmacist. We show it so you can see exactly what the maker states; we don’t verify or endorse those statements.
Supplement Facts
The label details for Triphala by Banyan Botanicals, sourced from the NIH Dietary Supplement Label Database.
Supplement Facts
| Ingredient | Amount | % DV |
|---|---|---|
| Terminalia chebula | 0.167 Teaspoon(s) | -- |
| Emblica officinalis | 0.167 Teaspoon(s) | -- |
| Terminalia bellirica | 0.167 Teaspoon(s) | -- |
Tap any ingredient to jump to its full detail below.
These statements are the manufacturer’s wording, reproduced from the product label — the label is saying it, not HelloPharmacist. We don’t verify or endorse them.
Suggested/Recommended/Usage/Directions
Suggested use: 1/4 to 1/2 teaspoon with warm water, once or twice daily, or as directed by your health practitioner.
FDA Statement of Identity
Dietary Supplement
Formula
Ayurvedic herbs
Formulation
USDA Organic Certified organic Certified Organic by: QAI
Seals/Symbols
USDA Organic
Is this label outdated? Report a formula or label change and our pharmacy team will review it.
Triphala by Banyan Botanicals label
The label scan from the NIH Dietary Supplement Label Database. Tap to enlarge.
Label images are published by the NIH Dietary Supplement Label Database for the version of this product on file. Always read your actual product label.
View the full label (PDF)The Ingredients in Triphala by Banyan Botanicals
These are the 3 active ingredients this product is made of. Select any to open its full monograph.
Serving size0.25 Teaspoon(s) Dosage formPowder Servings per container90 Amounts shown are per serving.
Most supplement products combine several ingredients, and a medication can interact with the product through any one of them. Each ingredient below shows whether it has known drug interactions.
Terminalia chebula
Interacts with93 drugs
Terminalia chebula, often called haritaki, is a fruit widely used in Ayurvedic medicine, most commonly for digestion and as a key part of the Triphala...
Terminalia chebula monograph & interactionsEmblica officinalis
Interacts with208 drugs
Indian gooseberry (amla) is a vitamin C-rich fruit used in Ayurvedic medicine for many purposes, from antioxidant support to cholesterol and digestion...
Emblica officinalis monograph & interactionsTerminalia bellirica
Interacts with86 drugs
Terminalia bellirica, often called 'Bibhitaki,' is a fruit long used in Ayurvedic medicine and is one of the three ingredients in the popular blend Tr...
Terminalia bellirica monograph & interactionsTriphala by Banyan Botanicals Drug Interactions
HelloPharmacist Interaction Report
Triphala by Banyan Botanicals interacts with medications through its three active ingredients: Terminalia chebula, Indian gooseberry (Emblica officinalis), and Terminalia bellirica.
The most serious documented interactions are Moderate in severity. Through Terminalia chebula and Indian gooseberry, this product may affect blood sugar control when taken with diabetes medications, raising the risk of low blood sugar (hypoglycemia).
Terminalia chebula may also increase blood levels of chlorzoxazone (a muscle relaxant) and omeprazole (a heartburn medication), potentially raising the risk of adverse effects from those drugs.
Read the full breakdown — every affected drug type, severity by severity
Indian gooseberry carries Moderate interactions with blood thinners (anticoagulants) and antiplatelet drugs like aspirin and clopidogrel. Clinical research shows it reduces platelet aggregation and increases bleeding time, which theoretically could raise bleeding risk if combined with these medications—though the research on this is conflicting.
Terminalia bellirica also interacts with diabetes medications through similar blood-sugar-lowering effects.
Altogether, these interactions span 214 individual medications. Use the medication checker on this page to verify your exact prescriptions before starting Triphala.
Check your own medications below · Editorial policy · How we use AI
Want to check YOUR meds against Triphala?
Ask about interactions with your drugs in plain English — “Can I take it with lisinopril?” — and we find you the answer in seconds, ingredient by ingredient.
Go to the checkerIngredients driving the most interactions
Individual Drug Interactions
The ingredients in Triphala interact with 214 drugs. Click any drug to see the details.
3 of the 3 ingredients in Triphala interact with drugs. Each result below shows which ingredient is responsible. Emblica officinalis Terminalia chebula Terminalia bellirica
DabigatranPradax, Pradaxa
How Dabigatran interacts with Triphala — through 1 ingredient. Tap an ingredient for the detail:
Emblica OfficinalisAnticoagulant/antiplatelet Drugs Moderate
Interaction Summary
Theoretically, Indian gooseberry may increase the risk of bleeding if used with anticoagulant or antiplatelet drugs; however, research is conflicting.
Read the full Emblica Officinalis + Dabigatran interactionPioglitazone, MetforminActoPlus Met
How Pioglitazone, Metformin interacts with Triphala — through 3 ingredients. Tap an ingredient for the detail:
Terminalia BelliricaAntidiabetes Drugs Moderate
Interaction Summary
Theoretically, concomitant use of Terminalia bellirica with antidiabetes drugs could affect blood sugar control and increase the risk of hypoglycemia.
Read the full Terminalia Bellirica + Pioglitazone, Metformin interactionTerminalia ChebulaAntidiabetes Drugs Moderate
Interaction Summary
Theoretically, concomitant use of Terminalia chebula with antidiabetes drugs could affect blood sugar control and increase the risk of hypoglycemia.
Read the full Terminalia Chebula + Pioglitazone, Metformin interactionEmblica OfficinalisAntidiabetes Drugs Moderate
Interaction Summary
Taking Indian gooseberry with antidiabetes drugs might increase the risk of hypoglycemia.
Read the full Emblica Officinalis + Pioglitazone, Metformin interactionReteplaseRetevase
How Reteplase interacts with Triphala — through 1 ingredient. Tap an ingredient for the detail:
Emblica OfficinalisAnticoagulant/antiplatelet Drugs Moderate
Interaction Summary
Theoretically, Indian gooseberry may increase the risk of bleeding if used with anticoagulant or antiplatelet drugs; however, research is conflicting.
Read the full Emblica Officinalis + Reteplase interactionRosiglitazone, GlimepirideAvandaryl
How Rosiglitazone, Glimepiride interacts with Triphala — through 3 ingredients. Tap an ingredient for the detail:
Terminalia BelliricaAntidiabetes Drugs Moderate
Interaction Summary
Theoretically, concomitant use of Terminalia bellirica with antidiabetes drugs could affect blood sugar control and increase the risk of hypoglycemia.
Read the full Terminalia Bellirica + Rosiglitazone, Glimepiride interactionTerminalia ChebulaAntidiabetes Drugs Moderate
Interaction Summary
Theoretically, concomitant use of Terminalia chebula with antidiabetes drugs could affect blood sugar control and increase the risk of hypoglycemia.
Read the full Terminalia Chebula + Rosiglitazone, Glimepiride interactionEmblica OfficinalisAntidiabetes Drugs Moderate
Interaction Summary
Taking Indian gooseberry with antidiabetes drugs might increase the risk of hypoglycemia.
Read the full Emblica Officinalis + Rosiglitazone, Glimepiride interactionEach ingredient & the kinds of drugs it affects
For each ingredient in Triphala with known interactions, here are the types of medications they can affect. Open any type for the detail — or search your exact drug in the checker above.
Emblica officinalis
Anticoagulant/Antiplatelet Drugs
Theoretically, Indian gooseberry may increase the risk of bleeding if used with anticoagulant or antiplatelet drugs; however, research is conflicting.
Clinical research shows that taking Indian gooseberry 500 mg as a single dose or twice daily for 10 days reduces platelet aggregation by about 24% to 36%, increases bleeding time by about 3.8-5.9 seconds, and increases clotting time by about 9.8-12.7 seconds when compared to baseline. However, taking Indian gooseberry 500 mg along with clopidogrel 75 mg or ecosprin 75 mg, as a single dose or for 10 days, does not significantly reduce platelet aggregation or increase bleeding time or clotting time when compared with clopidogrel 75 mg or ecosprin 75 mg alone. Until more is known, use caution when taking Indian gooseberry in combination with anticoagulant/antiplatelet drugs.
Antidiabetes Drugs
Taking Indian gooseberry with antidiabetes drugs might increase the risk of hypoglycemia.
Clinical research shows that taking Indian gooseberry fruit or fruit extract alone or in conjunction with antidiabetes medications can lower blood glucose levels. Dose adjustments to diabetes medications might be necessary.
Aspirin
Theoretically, Indian gooseberry may increase the risk of bleeding if used with aspirin; however, research is conflicting.
Clinical research shows that taking Indian gooseberry 500 mg as a single dose or twice daily for 10 days reduces platelet aggregation by about 24% to 36%, increases bleeding time by about 3.8-5.9 seconds, and increases clotting time by about 9.8-12.7 seconds when compared to baseline. However, taking a single dose of Indian gooseberry 500 mg along with ecosprin 75 mg, or taking a combination of Indian gooseberry 500 mg twice daily plus ecosprin 75 mg once daily for 10 days, does not significantly reduce platelet aggregation or increase bleeding time or clotting time when compared with ecosprin 75 mg alone.
Clopidogrel (Plavix)
Theoretically, Indian gooseberry may increase the risk of bleeding if used with clopidogrel; however, research is conflicting.
Clinical research shows that taking Indian gooseberry 500 mg as a single dose or twice daily for 10 days reduces platelet aggregation by about 24% to 36%, increases bleeding time by about 3.8-5.9 seconds, and increases clotting time by about 9.8-12.7 seconds when compared to baseline. However, taking a single dose of Indian gooseberry 500 mg along with clopidogrel 75 mg, or taking a combination of Indian gooseberry 500 mg twice daily plus clopidogrel 75 mg once daily for 10 days, does not significantly reduce platelet aggregation or increase bleeding time or clotting time when compared with clopidogrel 75 mg alone.
Terminalia chebula
Antidiabetes Drugs
Theoretically, concomitant use of Terminalia chebula with antidiabetes drugs could affect blood sugar control and increase the risk of hypoglycemia.
Animal research suggests that Terminalia chebula fruit extract has hypoglycemic effects.
Chlorzoxazone (Parafon Forte, Paraflex)
Theoretically, use of Terminalia chebula may increase the risk of adverse effects from chlorzoxazone.
Animal research shows that enteral administration of Terminalia chebula for 15 days prior to administration of chlorzoxazone increases blood levels of chlorzoxazone and decreases chlorzoxazone clearance. It is speculated that Terminalia chebula reduces the metabolism of chlorzoxazone by inhibiting cytochrome P450 2E1.
Omeprazole (Prilosec)
Theoretically, use of Terminalia chebula may increase the risk of adverse effects from omeprazole.
Animal research shows that enteral administration of Terminalia chebula for 15 days prior to administration of omeprazole increases blood levels of omeprazole and decreases omeprazole clearance. It is speculated that Terminalia chebula reduces the metabolism of omeprazole by inhibiting cytochrome P450 2C19.
Terminalia bellirica
Antidiabetes Drugs
Theoretically, concomitant use of Terminalia bellirica with antidiabetes drugs could affect blood sugar control and increase the risk of hypoglycemia.
Animal research suggests that Terminalia bellirica fruit extract, alone or in combination with Terminalia chebula and Indian gooseberry, has hypoglycemic effects. This activity has not been shown in humans.
Brand information
Manufacturer and brand details for Triphala, from the product label.
Banyan Botanicals
See all Banyan Botanicals products- Name
- Banyan Botanicals
- City
- Albuquerque
- State
- NM
- ZipCode
- 87113
- Phone Number
- 1-800-953-6424
- Web Address
- banyanbotanicals.com
Triphala by Banyan Botanicals: Common Questions
Does Triphala by Banyan Botanicals interact with any medications?
How can one product interact with so many drugs?
Where does this information come from?
Can I take Triphala if I'm pregnant?
Is Triphala safe while breastfeeding?
What's Indian gooseberry used for in Triphala?
Does Triphala really help with constipation or digestion?
What side effects has Triphala been reported to cause?
Should I be concerned about the 214 medication interactions listed?
Written and reviewed by the HelloPharmacist editorial staff. Our editorial policy
Not sure if Triphala is safe with your meds?
Our pharmacists answer your medication & supplement questions — free.
Label information is sourced from the NIH Dietary Supplement Label Database and reflects the product version on file; always read your actual product label. This page is for education only and is not a substitute for professional medical advice. Confirm with your pharmacist or doctor before combining supplements and medications.
The Full Monographs Behind Triphala’s Ingredients
Every ingredient we hold a full HelloPharmacist monograph for — uses, evidence, safety, and the complete interaction list.
Terminalia Chebula
Interacts with 93 drugsTerminalia chebula, often called haritaki, is a fruit widely used in Ayurvedic medicine, most commonly for digestion and as a key part of the Triphala blend. Early laboratory and small human...
Read the full Terminalia Chebula monograph → Herb & supplement monographIndian Gooseberry
Interacts with 208 drugsIndian gooseberry (amla) is a vitamin C-rich fruit used in Ayurvedic medicine for many purposes, from antioxidant support to cholesterol and digestion. Early research is promising for some u...
Read the full Indian Gooseberry monograph → Herb & supplement monographTerminalia Bellirica
Interacts with 86 drugsTerminalia bellirica, often called 'Bibhitaki,' is a fruit long used in Ayurvedic medicine and is one of the three ingredients in the popular blend Triphala. Early laboratory and small human...
Read the full Terminalia Bellirica monograph →Sources & How We Checked
Triphala's label data comes from the NIH Dietary Supplement Label Database; the ingredient interaction data is from the Natural Medicines database, reviewed by our pharmacists.
- NIH Dietary Supplement Label Database (DSLD) — The official product label on file for this supplement.
- Natural Medicines (Therapeutic Research Center) — Evidence-graded clinical reference behind the ingredient interaction data.
Content is written and reviewed by licensed HelloPharmacist pharmacists. See our data sources and editorial standards for how this information is built and checked.
The 19 references behind this product’s interaction data
Every citation that drives the interaction findings for this product’s ingredients, from the evidence-graded Natural Medicines (TRC Healthcare) database. Open an ingredient to browse its citations — links open the study on PubMed or the publisher’s site.
Terminalia Chebula 9 references
- Chevallier A. Encyclopedia of Medicinal Plants. New York, NY: DK Publishing, 1996.
- Sabu, M. C. and Kuttan, R. Anti-diabetic activity of medicinal plants and its relationship with their antioxidant property. J Ethnopharmacol. 2002;81(2):155-160. PubMed
- Murali, Y. K., Anand, P., Tandon, V., Singh, R., Chandra, R., and Murthy, P. S. Long-term effects of Terminalia chebula Retz. on hyperglycemia and associated hyperlipidemia, tissue glycogen content and in vitro release of insulin in streptozotocin induced
- Senthilkumar, G. P. and Subramanian, S. Evaluation of antioxidant potential of Terminalia chebula fruits studies in streptozotocin-induced diabetic rats. Pharmaceutical Biology (Netherlands) 2007;45:511-518.
- Wu G, Dong Z, Dong J, et al. Effects of mongolian medicine Terminalia chebula Retz. on 6 CYP450 enzymes in rats. Int J Clin Exp Pathol 2020;13(12):3128-3138.
- Donato F, Raffetti E, Toninelli G, Festa A, Scarcella C, Castellano M; TRIGU Project Working Group. Guggulu and Triphala for the Treatment of Hypercholesterolaemia: A Placebo-Controlled, Double-Blind, Randomised Trial. Complement Med Res 2021;28(3):216-22 PubMed
- Das A, Naveen J, Sreerama YN, Gnanesh Kumar BS, Baskaran V. Low-glycemic foods with wheat, barley and herbs (Terminalia chebula, Terminalia bellerica and Emblica officinalis) inhibit a-amylase, a-glucosidase and DPP-IV activity in high fat and low dose st
- Eltimamy M, Elshamarka M, Aboelsaad M, Sayed M, Moawad H. Effects of alcoholic extract of Terminalia Chebula dried fruit on blood biochemical profile in diabetic rats. J Diabetes Metab Disord 2022;21(1):159-170. PubMed
- Agrawal OD, Kulkarni YA. Treatment with Terminalia chebula extract reduces insulin resistance, hyperglycemia and improves SIRT1 expression in type 2 diabetic rats. Life (Basel) 2023;13(5):1168. PubMed
Indian Gooseberry 6 references
- Sabu, M. C. and Kuttan, R. Anti-diabetic activity of medicinal plants and its relationship with their antioxidant property. J Ethnopharmacol. 2002;81(2):155-160. PubMed
- Fatima N, Pingali U, Muralidhar N. Study of pharmacodynamic interaction of Phyllanthus emblica extract with clopidogrel and ecosprin in patients with type II diabetes mellitus. Phytomedicine. 2014;21(5):579-85. PubMed
- Shanmugarajan D, Girish C, Harivenkatesh N, Chanaveerappa B, Prasanna Lakshmi NC. Antihypertensive and pleiotropic effects of Phyllanthus emblica extract as an add-on therapy in patients with essential hypertension-A randomized double-blind placebo-contro
- Akhtar MS, Ramzan A, Ali A, Ahmad M. Effect of amla fruit (Emblica officinalis Gaertn.) on blood glucose and lipid profile of normal subjects and type 2 diabetic patients. Int J Food Sci Nutr. 2011;62(6):609-16.
- Usharani P, Fatima N, Muralidhar N. Effects of Phyllanthus emblica extract on endothelial dysfunction and biomarkers of oxidative stress in patients with type 2 diabetes mellitus: a randomized, double-blind, controlled study. Diabetes Metab Syndr Obes. 20 PubMed
- Majeed M, Mundkur L, Paulose S, Nagabhushanam K. Novel Emblica officinalis extract containing ß-glucogallin vs. metformin: a randomized, open-label, comparative efficacy study in newly diagnosed type 2 diabetes mellitus patients with dyslipidemia. Food Fu
Terminalia Bellirica 4 references
- Chevallier A. Encyclopedia of Medicinal Plants. New York, NY: DK Publishing, 1996.
- Sabu, M. C. and Kuttan, R. Anti-diabetic activity of medicinal plants and its relationship with their antioxidant property. J Ethnopharmacol. 2002;81(2):155-160. PubMed
- Donato F, Raffetti E, Toninelli G, Festa A, Scarcella C, Castellano M; TRIGU Project Working Group. Guggulu and Triphala for the Treatment of Hypercholesterolaemia: A Placebo-Controlled, Double-Blind, Randomised Trial. Complement Med Res 2021;28(3):216-22 PubMed
- Das A, Naveen J, Sreerama YN, Gnanesh Kumar BS, Baskaran V. Low-glycemic foods with wheat, barley and herbs (Terminalia chebula, Terminalia bellerica and Emblica officinalis) inhibit a-amylase, a-glucosidase and DPP-IV activity in high fat and low dose st
See these in context on the Terminalia Bellirica monograph →
Parts of this content are provided by the Therapeutic Research Center, LLC.
DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.
© 2021 Therapeutic Research Center, LLC